Furthermore, as mentioned above, D. Rogacka et al. demonstrated that metformin, besides its impact on glucose uptake into podocytes, can decrease glomerular filtration barrier permeability by activation of SIRT1 and AMPK and prevention of hyperglycemia-induced reduction in SIRT1 protein levels [122]. Here, PRKAA1 is linked to Hyperglycemia.